中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:(Chunquan ZHU)

1.Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease.

Jie TONG ; Dongjie LI ; Hongbo MENG ; Diyang SUN ; Xiuting LAN ; Min NI ; Jiawei MA ; Feiyan ZENG ; Sijia SUN ; Jiangtao FU ; Guoqiang LI ; Qingxin JI ; Guoyan ZHANG ; Qirui SHEN ; Yuanyuan WANG ; Jiahui ZHU ; Yi ZHAO ; Xujie WANG ; Yi LIU ; Shenxi OUYANG ; Chunquan SHENG ; Fuming SHEN ; Pei WANG

Acta Pharmaceutica Sinica B 2022;12(9):3650-3666

2.Antifungal activity study on HDAC inhibitor Rocilinostat

Tianbao ZHU ; Jie TU ; Chunquan SHENG ; Defeng XU ; Na LIU

Journal of Pharmaceutical Practice 2022;40(1):44-47

3.Clinical research of ankle fusion with vascularised semi-split fibular flap via lateral approach

Sang HU ; Zhe XIE ; Chunquan ZHU ; Yu DENG ; Guorong YU ; Li YU

Chinese Journal of Microsurgery 2022;45(5):508-514

4.Posterior short-segment pedicle screw fixation at the injured level for thoracolumbar spine fractures

Yunrong ZHU ; Xiaojian YE ; Jiangmin YU ; Yuquan JIANG ; Huixue WANG ; Chunquan FAN ; Hailong HE ; Guohua XU

Chinese Journal of Trauma 2010;26(3):221-224

5.Study on the efficacy and safety of ultrasound ablation in treatment of uterine fibroids

Wenzhi CHEN ; Liangdan TANG ; Wuwei YANG ; Yan ZHANG ; Jing LI ; Wenxiu XIA ; Jiemin ZHOU ; Baorang ZHU ; Chunquan ZHAO ; Hua LINGHU ; Jinyun CHEN ; Li ZHU ; Yongbin DENG ; Zhibiao WANG

Chinese Journal of Obstetrics and Gynecology 2010;45(12):909-912

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO